Intrinsiqq
NextCure, Inc. logo

NextCure, Inc. Insider Trading

NXTC

Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in May 2019.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
May 2019
May 13, 2019

Get an email when NXTC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 11
    Adar1 Capital Management, LLC
    Large holder · bought 12,333 at $5.10
    63K
    1.7% of stake
  • Nov 5 – 6
    Adar1 Capital Management, LLC
    Large holder · bought 4,686 at avg $5.10
    24K
    0.6% of stake
  • Oct 23 – 27
    Adar1 Capital Management, LLC
    Large holder · bought 10,851 at avg $4.95
    54K
    1.5% of stake
  • Aug 10No plan
    Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd.
    Large holder · sold 30,000 at $6.16
    185K
    8.9% of stake
  • Jul 30 – 31
    Adar1 Capital Management, LLC
    Large holder · bought 329,153 at avg $4.93
    $1.62M
    84% of stake
  • Jul 27 – 29
    Adar1 Capital Management, LLC
    Large holder · bought 17,608 at avg $4.98
    88K
    4.7% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NXTC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with NXTC

CompareIntrinsic value
PRLDPrelude Therapeutics Incorporated
$3.23-0.77%46
CAPRCapricor Therapeutics Inc.
$7.59+0.80%10
JANXJanux Therapeutics Inc.
$10.08-2.04%40
QUREuniQure N.V.
$19.35-4.35%10
BGMBGM Group Ltd.
$8.00+0.00%10
SLGLSol-Gel Technologies Ltd.
$55.17+2.02%65
SCYXScynexis, Inc.
$2.38-8.64%40
NAMSNewAmsterdam Pharma Co. N.V.
$18.41-5.64%10

Spot a number that looks wrong? Check it in NXTC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing NXTC

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.